GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IQVIA Holdings Inc (BSP:I1QV34) » Definitions » Future 3-5Y EPS without NRI Growth Rate

IQVIA Holdings (BSP:I1QV34) Future 3-5Y EPS without NRI Growth Rate : 9.02 (As of Jul. 16, 2025)


View and export this data going back to 2020. Start your Free Trial

What is IQVIA Holdings Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, IQVIA Holdings's Future 3-5Y EPS without NRI Growth Rate is 9.02.

Competitive Comparison of IQVIA Holdings's Future 3-5Y EPS without NRI Growth Rate

For the Diagnostics & Research subindustry, IQVIA Holdings's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IQVIA Holdings's Future 3-5Y EPS without NRI Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IQVIA Holdings's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where IQVIA Holdings's Future 3-5Y EPS without NRI Growth Rate falls into.


;
;

IQVIA Holdings  (BSP:I1QV34) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

IQVIA Holdings Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of IQVIA Holdings's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

IQVIA Holdings Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IQVIA Holdings Inc (BSP:I1QV34) » Definitions » Future 3-5Y EPS without NRI Growth Rate
Comparable Companies
MTD NTRA LH WAT A DGX ILMN IDXX RVTY ICLR TSE:2397 TMO DHR XSWX:LONN SHSE:603259 XPAR:BIM XPAR:ERF QGEN EXAS MEDP
Traded in Other Exchanges
IQV:USA IQV:Mexico 0JDM:UK QTS:Germany IQVH:Austria
Address
2400 Ellis Road, Durham, NC, USA, 27703
Website
https://www.iqvia.com
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

IQVIA Holdings Headlines

No Headlines